Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HEPATITIS-A VACCINE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 72 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Leder, K; Weller, PF; Wilson, ME
      Travel vaccines and elderly persons: Review of vaccines available in the United States

      CLINICAL INFECTIOUS DISEASES
    2. Dennehy, PH
      Active immunization in the United States: Developments over the past decade

      CLINICAL MICROBIOLOGY REVIEWS
    3. Wilson, ME
      Travel-related vaccines

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    4. Lopez, EL; Xifro, MD; Torrado, LE; De Rosa, MF; Gomez, R; Dumas, R; Wood, SC; Contrini, MP
      Safety and immunogenicity of a pediatric formulation of inactivated hepatitis A vaccine in Argentinean children

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    5. Lesprit, P
      Vaccination and antiinfectious protection in patients with acquired or congenital immunodeficiency

      PRESSE MEDICALE
    6. Joines, RW; Blatter, M; Abraham, B; Xie, F; De Clercq, N; Baine, Y; Reisinger, KS; Kuhnen, A
      A prospective, randomized, comparative US trial of a combination hepatitisA and B vaccine (Twinrix (R)) with corresponding monovalent vaccines (Havrix (R) and Engerix-B (R)) in adults

      VACCINE
    7. Moingeon, P; Haensler, J; Lindberg, A
      Towards the rational design of Th1 adjuvants

      VACCINE
    8. Clarke, P; Kitchin, N; Souverbie, F
      A randomised comparison of two inactivated hepatitis A vaccines, Avaxim (TM) and Vaqta (TM), given as a booster to subjects primed with Avaxim (TM)

      VACCINE
    9. Linglof, T; van Hattum, J; Kaplan, KM; Corrigan, J; Duval, I; Jensen, E; Kuter, B
      An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity

      VACCINE
    10. Stroffolini, T; Mele, A; Sagliocca, L
      Vaccination policy against hepatitis A in Italy

      VACCINE
    11. Van Damme, P; Van der Wielen, M
      Combining hepatitis A and B vaccination in children and adolescents

      VACCINE
    12. Campbell, AL; Bryant, KA
      Routine childhood immunizations

      PRIMARY CARE
    13. Arguedas, MR; Fallon, MB
      Prevention in liver disease

      AMERICAN JOURNAL OF THE MEDICAL SCIENCES
    14. Edwards, KM; Gruber, WC
      Immunization in hematopoietic cell transplantation

      PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE
    15. Hilleman, MR
      Vaccines in historic evolution and perspective - A narrative of vaccine discoveries

      JOURNAL OF HUMAN VIROLOGY
    16. Lee, SD
      Asian perspectives on viral hepatitis A

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    17. Sohn, YM; Rho, HO; Park, MS; Park, JH; Choi, BY; Ki, M; Jang, WI
      The changing epidemiology of hepatitis A in children and the considerationof active immunization in Korea

      YONSEI MEDICAL JOURNAL
    18. Hu, YZ; Tan, SG; Shao, CW; Jin, WX; Ji, QY; He, JH; Chen, HB; Yan, J
      Safety and immunogenicity of lyophilized, live attenuated hepatitis A vaccine in non-human primate model

      CHINESE MEDICAL JOURNAL
    19. Greub, G; Genton, B; Safary, A; Thoelen, S; Frei, PC
      Comparison of the reactogenicity and immunogenicity of a two injection combined high-dose hepatitis A and hepatitis B vaccine to those of Twinrix (TM)

      VACCINE
    20. Bryan, JP; Henry, CH; Hoffman, AG; South-Paul, JE; Smith, JA; Cruess, D; Spieker, JMR; de Medina, M
      Randomized, cross-over, controlled comparison of two inactivated hepatitisA vaccines

      VACCINE
    21. Hilleman, MR
      Vaccines in historic evolution and perspective: a narrative of vaccine discoveries

      VACCINE
    22. Ortiz, A; Cajal, Y; Haro, I; Reig, F; Alsina, MA
      Fluorescence study on the interaction of a multiple antigenic peptide fromhepatitis A virus with lipid vesicles

      BIOPOLYMERS
    23. Bell, BP
      Hepatitis A and hepatitis B vaccination of patients with chronic liver disease

      ACTA GASTRO-ENTEROLOGICA BELGICA
    24. Riley, TR; Smith, JP
      Preventive care in chronic liver disease

      JOURNAL OF GENERAL INTERNAL MEDICINE
    25. LU MY; CHANG MH; TSAI KS; CHEN DS
      HEPATITIS-A VACCINE IN HEALTHY-ADULTS - A COMPARISON OF IMMUNOGENICITY AND REACTOGENICITY BETWEEN 2-DOSE AND 3-DOSE REGIMENS

      Vaccine
    26. de Febres, OC; de Petrola, MC; de Escalona, LC; Naveda, O; Naveda, M; Estopinan, M; Bordones, G; Zambrano, B; Garcia, A; Dumas, R
      Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children

      VACCINE
    27. Piazza, M; Safary, A; Vegnente, A; Soncini, R; Pensati, P; Sardo, M; Orlando, R; Tosone, G; Picciotto, L
      Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme

      VACCINE
    28. Chan, CY; Lee, SD; Yu, MI; Wang, YJ; Chang, FY; Lo, KJ
      Long-term follow-up of hepatitis A vaccination in children

      VACCINE
    29. Braconier, JH; Wennerholm, S; Norrby, SR
      Comparative immunogenicity and tolerance of Vaqta (TM) and Havrix (TM)

      VACCINE
    30. Dagan, R; Greenberg, D; Goldenbertg-Gehtman, P; Vidor, E; Briantais, P; Pinsk, V; Athias, O; Dumas, R
      Safety and immunogenicity of a new formulation of an inactivated hepatitisA vaccine

      VACCINE
    31. Gluck, R
      Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs)

      VACCINE
    32. Walter, EB; Hornick, RB; Poland, GA; Tucker, R; Bland, CL; Clements, DA; Rhamstine, CC; Jacobson, RM; Brown, L; Gress, JO; Harris, KE; Wiens, BL; Nalin, DR
      Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults

      VACCINE
    33. Domart, M; Mlika-Cabanne, N; Henzel, D; Pouliquen, A; Florentin, A; Marande, JL; Xerri, B; Aufrere, A; Larouze, B
      Hepatitis A among health workers in Paris hospitals

      JOURNAL OF MEDICAL VIROLOGY
    34. REUTTER J; BART PA; FRANCIOLI P; SAFARY A; FREI PC
      PRODUCTION OF ANTIBODY TO HEPATITIS-A VIRUS AND HEPATITIS-B SURFACE-ANTIGEN MEASURED AFTER COMBINED HEPATITIS-A HEPATITIS-B VACCINATION IN 242 ADULT VOLUNTEERS/

      Journal of viral hepatitis
    35. HILLEMAN MR
      6 DECADES OF VACCINE DEVELOPMENT - A PERSONAL HISTORY

      Nature medicine
    36. SCHWARTZ E; RAVEH D
      THE PREVALENCE OF HEPATITIS-A ANTIBODIES AMONG ISRAELI TRAVELERS AND THE ECONOMIC-FEASIBILITY OF SCREENING BEFORE VACCINATION

      International journal of epidemiology
    37. FAN PC; CHANG MH; LEE PI; SAFARY A; LEE CY
      FOLLOW-UP IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VIRUS-VACCINE IN HEALTHY-CHILDREN - RESULTS AFTER 5 YEARS

      Vaccine
    38. Saliou, P
      Vaccines for the prevention of diseases transmitted by the feco-oral route.

      BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE
    39. WIEDERMANN G; KUNDI M; AMBROSCH F
      ESTIMATED PERSISTENCE OF ANTI-HAV ANTIBODIES AFTER SINGLE-DOSE AND BOOSTER HEPATITIS-A VACCINATION (0-6 SCHEDULE)

      Acta Tropica
    40. BEEKMANN SE; DOEBBELING BN
      FRONTIERS OF OCCUPATIONAL-HEALTH - NEW VACCINES, NEW PROPHYLACTIC REGIMENS, AND MANAGEMENT OF THE HIV-INFECTED WORKER

      Infectious disease clinics of North America
    41. TOERNER JG; MATHEWS WC
      GUIDELINES FOR IMMUNIZATIONS IN HIV-INFECTED PATIENTS

      Immunology and allergy clinics of North America
    42. FUJIYAMA S; ODOH K; TANAKA M; KURAMOTO I; TOMITA K
      EVALUATION OF THE TIMING OF THE BOOSTER INJECTION AFTER A PRIMARY VACCINATION AGAINST HEPATITIS-A

      Journal of gastroenterology and hepatology
    43. DUMAS R; FORRAT R; LANG J; FARINELLI T; LOUTAN L
      SAFETY AND IMMUNOGENICITY OF A NEW INACTIVATED HEPATITIS-A VACCINE INCONCURRENT ADMINISTRATION WITH A TYPHOID-FEVER VACCINE OR A TYPHOID-FEVER PLUS YELLOW-FEVER VACCINE

      Advances in therapy
    44. ZUCKERMAN J; PEYRON F; WALLON M; GAY F; DELOLME H; BRIANTAIS P; VIDOR E
      COMPARISON OF THE SAFETY AND IMMUNOGENICITY OF 2 INACTIVATED HEPATITIS-A VACCINES

      Advances in therapy
    45. MAIWALD H; JILG W; BOCK HL; LOSCHER T; VONSONNENBURG F
      LONG-TERM PERSISTENCE OF ANTI-HAV ANTIBODIES FOLLOWING ACTIVE IMMUNIZATION WITH HEPATITIS-A VACCINE

      Vaccine
    46. AMBROSCH F; WIEDERMANN G; JONAS S; ALTHAUS B; FINKEL B; GLUCK R; HERZOG C
      IMMUNOGENICITY AND PROTECTIVITY OF A NEW LIPOSOMAL HEPATITIS-A VACCINE

      Vaccine
    47. TOTOS G; GIZARIS V; PAPAEVANGELOU G
      HEPATITIS-A VACCINE - PERSISTENCE OF ANTIBODIES 5 YEARS AFTER THE FIRST VACCINATION

      Vaccine
    48. REUMAN PD; KUBILIS P; HURNI W; BROWN L; NALIN D
      THE EFFECT OF AGE AND WEIGHT ON THE RESPONSE TO FORMALIN-INACTIVATED,ALUM-ADJUVANTED HEPATITIS-A VACCINE IN HEALTHY-ADULTS

      Vaccine
    49. LEE SD; CHAN CY; YU MI; WANG YJ; CHANG FY; LO KJ; SAFARY A
      SAFETY AND IMMUNOGENICITY OF INACTIVATED HEPATITIS-A VACCINE IN PATIENTS WITH CHRONIC LIVER-DISEASE

      Journal of medical virology
    50. HAGEN AJ; OLIVER CN; SITRIN RD
      OPTIMIZATION AND SCALE-UP OF SOLVENT-EXTRACTION IN PURIFICATION OF HEPATITIS-A VIRUS (VAQTA(R))

      Biotechnology and bioengineering
    51. SABBAJ S; KIYONO H; MCGHEE JR
      MUCOSAL IMMUNIZATION FOR ENTERIC DISEASES - CURRENT PRACTICE AND FUTURE-PROSPECTS

      Biodrugs
    52. ZUCKERMAN JN; MOORE S; SMITH J; TYRRELL H; BAXTER A; LEE CA
      A STUDY TO ASSESS THE IMMUNOGENICITY, REACTOGENICITY AND SAFETY OF HEPATITIS-A VACCINE ADMINISTERED SUBCUTANEOUSLY TO PATIENTS WITH CONGENITAL COAGULATION DISORDERS

      Haemophilia
    53. LO YC; LEE SS; WONG KH; LIM WL
      INACTIVATED HEPATITIS-A VACCINE IN HEALTHY CHINESE ADULTS

      Journal of internal medicine
    54. NETTLEMAN MD
      PREPARING THE INTERNATIONAL TRAVELER

      Gastroenterology clinics of North America
    55. RAJAN E; ALBLOUSHI S; OFARRELL B; SHATTOCK A; COURTNEY MG; SAFARY A; FIELDING JF
      2-YEAR OLD HEPATITIS-A VACCINE IS AS GOOD AS NEW

      Vaccine
    56. LANGER BCA; LOVESTAD A; FROSNER GG
      HIGH IMMUNOGENICITY AND GOOD TOLERABILITY OF A NEW HEPATITIS-A VACCINE CANDIDATE

      Vaccine
    57. FISCH A; CADILHAC P; VIDOR E; PRAZUCK T; DUBLANCHET A; LAFAIX C
      IMMUNOGENICITY AND SAFETY OF A NEW INACTIVATED HEPATITIS-A VACCINE - A CLINICAL-TRIAL WITH COMPARISON OF ADMINISTRATION ROUTE

      Vaccine
    58. GIL A; GONZALEZ A; DALRE R; CALERO R
      INTERFERENCE ASSESSMENT OF YELLOW-FEVER VACCINE WITH THE IMMUNE-RESPONSE TO A SINGLE-DOSE INACTIVATED HEPATITIS-A VACCINE (1440-ELU) - A CONTROLLED-STUDY IN ADULTS

      Vaccine
    59. TILZEY AJ; PALMER SJ; HARRINGTON C; ODOHERTY MJ
      HEPATITIS-A VACCINE RESPONSES IN HIV-POSITIVE PERSONS WITH HEMOPHILIA

      Vaccine
    60. ZUCKERMAN JN; POWELL L; LEQUIN RM; ZUCKERMAN AJ
      DETERMINATION OF HEPATITIS-A ANTIBODY-RESPONSE TO VACCINATION BY AN ENZYME-IMMUNOASSAY

      Journal of virological methods
    61. HODES DS
      CHILDHOOD IMMUNIZATIONS - 1996

      The Mount Sinai journal of medicine
    62. GARDNER P; EICKHOFF T; POLAND GA; GROSS P; GRIFFIN M; LAFORCE M; SCHAFFNER W; STRIKAS R
      ADULT IMMUNIZATIONS

      Annals of internal medicine
    63. GOILAV C; ZUCKERMAN J; LAFRENZ M; VIDOR E; LAUWERS S; RATHEAU C; BENICHOU G; ZUCKERMAN A
      IMMUNOGENICITY AND SAFETY OF A NEW INACTIVATED HEPATITIS-A VACCINE INA COMPARATIVE-STUDY

      Journal of medical virology
    64. KURAMOTO I; FUJIYAMA S; MATSUSHITA K; SATO T
      IMMUNE-RESPONSE AFTER HEPATITIS-A VACCINATION IN HEMODIALYSIS-PATIENTS - COMPARISON WITH HEPATITIS-B VACCINATION

      Journal of gastroenterology and hepatology
    65. BRINDLE RJ; MORRIS CA; BERGER R; KURTZ JB
      INADEQUATE RESPONSE TO INTRADERMAL HEPATITIS-A VACCINE

      Vaccine
    66. FUJIYAMA S; ODOH K; KURAMOTO I; MIZUNO K; TSURUSAKI R; SATO T
      CURRENT SEROEPIDEMIOLOGICAL STATUS OF HEPATITIS-A WITH A COMPARISON OF ANTIBODY-TITERS AFTER INFECTION AND VACCINATION

      Journal of hepatology
    67. KURAMOTO I; FUJIYAMA S; ODOH K; MIZUNO K; SATO T
      LONG-TERM FOLLOW-UP OF ANTIBODY-TITERS AFTER HEPATITIS-A VACCINATION

      HEPATOLOGY RESEARCH
    68. HORNG YC; CHANG MH; LEE CY; SAFARY A; ANDRE FE; CHEN DS
      SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN HEALTHY-CHILDREN

      The Pediatric infectious disease journal
    69. HORNG YC; CHANG MH; LEE CY; SAFARY A; ANDRE FE; CHEN DS
      SAFETY AND IMMUNOGENICITY OF HEPATITIS-A VACCINE IN HEALTHY ADULT VOLUNTEERS

      Journal of gastroenterology and hepatology
    70. SHOUVAL D; ASHUR Y; ADLER R; LEWIS JA; MILLER W; KUTER B; BROWN L; NALIN DR
      SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE - EFFECTS OF SINGLE AND BOOSTER INJECTIONS, AND COMPARISON TO ADMINISTRATION OF IMMUNE GLOBULIN

      Journal of hepatology
    71. JILG W; BITTNER R; SCHATZL H; RASSHOFER R; SCHMIDT M; DEINHARDT F
      THE IMMUNE-RESPONSE TO DIFFERENT DOSES OF INACTIVATED HEPATITIS-A VACCINE

      Journal of hepatology
    72. PAPAEVANGELOU G; TOTOS G; ROUMELIOTOU A; SAFARY A
      HEPATITIS-A VACCINATION IN GREEK MILITARY RECRUITS

      Journal of medical virology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/21 alle ore 09:41:57